Biblio
Export 292 results:
[ Author] Title Type Year Filters: First Letter Of Last Name is S [Clear All Filters]
“Distinct Neuroanatomical Correlates of Neuropsychiatric Symptoms in the Three Main Forms of Genetic Frontotemporal Dementia in the GENFI Cohort.”, J Alzheimers Dis, vol. 65, no. 1, pp. 147-163, 2018.
, “APP Mutations in Cerebral Amyloid Angiopathy with or without Cortical Calcifications: Report of Three Families and a Literature Review.”, J Alzheimers Dis, vol. 56, no. 1, pp. 37-46, 2017.
, “The Mechanism Underlying Amyloid Polymorphism is Opened for Alzheimer's Disease Amyloid-β Peptide.”, J Alzheimers Dis, vol. 54, no. 2, pp. 821-30, 2016.
, “Insight into the Dissociation of Behavior from Histology in Synucleinopathies and in Related Neurodegenerative Diseases.”, J Alzheimers Dis, vol. 52, no. 3, pp. 831-41, 2016.
, “Everyday Memory in Patients with Alzheimer's Disease: Fragmentary and Distorted.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1489-1498, 2017.
, “Generation of Transgenic Cynomolgus Monkeys Overexpressing the Gene for Amyloid-β Precursor Protein.”, J Alzheimers Dis, vol. 75, no. 1, pp. 45-60, 2020.
, “Usefulness of Dual-Point Amyloid PET Scans in Appropriate Use Criteria: A Multicenter Study.”, J Alzheimers Dis, vol. 65, no. 3, pp. 765-779, 2018.
, “A Multifunctional Biocompatible Drug Candidate is Highly Effective in Delaying Pathological Signs of Alzheimer's Disease in 5XFAD Mice.”, J Alzheimers Dis, vol. 58, no. 2, pp. 389-400, 2017.
, “Passive Assessment of Routine Driving with Unobtrusive Sensors: A New Approach for Identifying and Monitoring Functional Level in Normal Aging and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1427-1437, 2017.
, “SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging.”, J Alzheimers Dis, vol. 61, no. 1, pp. 401-414, 2018.
, “Small Vessel Cerebrovascular Pathology Identified by Magnetic Resonance Imaging Is Prevalent in Alzheimer's Disease and Mild Cognitive Impairment: A Potential Target for Intervention.”, J Alzheimers Dis, vol. 65, no. 1, pp. 293-302, 2018.
, “Behavioral and Psychological Symptoms of Dementia in Different Dementia Disorders: A Large-Scale Study of 10,000 Individuals.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1307-1318, 2022.
, “Prediction and Early Detection of Alzheimer's Dementia: Professional Disclosure Practices and Ethical Attitudes.”, J Alzheimers Dis, vol. 62, no. 1, pp. 145-155, 2018.
, “A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR.”, J Alzheimers Dis, vol. 67, no. 1, pp. 181-195, 2019.
, “Longitudinally Increasing Elevated Asymmetric Flortaucipir Binding in a Cognitively Unimpaired Amyloid-Negative Older Individual.”, J Alzheimers Dis, vol. 85, no. 1, pp. 59-64, 2021.
, “Assessing the Limitations and Biases in the Current Understanding of Chronic Traumatic Encephalopathy.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1067-1076, 2018.
, “Functional Connectivity Alterations of the Temporal Lobe and Hippocampus in Semantic Dementia and Alzheimer's Disease.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1461-1475, 2020.
, “Dogs with Cognitive Dysfunction as a Spontaneous Model for Early Alzheimer's Disease: A Translational Study of Neuropathological and Inflammatory Markers.”, J Alzheimers Dis, vol. 52, no. 2, pp. 433-49, 2016.
, “Methods for the Specific Detection and Quantitation of Amyloid-β Oligomers in Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 53, no. 1, pp. 53-67, 2016.
, “Levels of Retinal Amyloid-β Correlate with Levels of Retinal IAPP and Hippocampal Amyloid-β in Neuropathologically Evaluated Individuals.”, J Alzheimers Dis, vol. 73, no. 3, pp. 1201-1209, 2020.
, “Increase of α-Secretase ADAM10 in Platelets Along Cognitively Healthy Aging.”, J Alzheimers Dis, vol. 50, no. 3, pp. 817-26, 2016.
, “Longitudinal Memory Profiles in Behavioral-Variant Frontotemporal Dementia and Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 3, pp. 775-82, 2016.
, “Dietary high cholesterol and trace metals in the drinking water increase levels of ABCA1 in the rabbit hippocampus and temporal cortex.”, J Alzheimers Dis, vol. 49, no. 1, pp. 201-9, 2016.
, “Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer's Disease-Like Pathology.”, J Alzheimers Dis, vol. 64, no. 2, pp. 379-392, 2018.
, “Dipeptidyl-Peptidase Activity of Meprin β Links N-truncation of Aβ with Glutaminyl Cyclase-Catalyzed pGlu-Aβ Formation.”, J Alzheimers Dis, vol. 66, no. 1, pp. 359-375, 2018.
,